|
|
||||||||
Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Womens Hospital, and Harvard Medical School, Boston, MA 02115
It has been known for decades that circulating human CD4 cells can express functional MHC class II molecules that induce T cell nonresponsiveness with Ag presentation. Because there is significant expression of MHC class II (MHC-II) determinants (DR) on a subpopulation CD4+CD25high regulatory T cells (Treg), we examined the function of CD4 cells expressing MHC-DR. We demonstrate that MHC-II expression on human CD4+CD25high T cells identifies a functionally distinct population of Treg that induces early contact-dependent suppression that is associated with high Foxp3 expression. In striking contrast, MHC-II CD4+CD25high Treg induce early IL-4 and IL-10 secretion and a late Foxp3-associated contact-dependent suppression. The DR expressing CD25high Treg express higher levels of Foxp3 message and protein, compared with the DRCD25high Treg population. Direct single-cell cloning of CD4+CD25high Treg revealed that, regardless of initial DR expression, ex vivo expression of CD25high, and not DR, predicted which clones would exhibit contact-dependent suppression, high levels of Foxp3 message, and an increased propensity to become constitutive for DR expression. Thus, the direct ex vivo expression of MHC-II in the context of CD25high identifies a mature, functionally distinct regulatory T cell population involved in contact-dependent in vitro suppression.
This article has been cited by other articles:
![]() |
K. Venken, N. Hellings, T. Broekmans, K. Hensen, J.-L. Rummens, and P. Stinissen Natural Naive CD4+CD25+CD127low Regulatory T Cell (Treg) Development and Function Are Disturbed in Multiple Sclerosis Patients: Recovery of Memory Treg Homeostasis during Disease Progression J. Immunol., May 1, 2008; 180(9): 6411 - 6420. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Swiatek-de Lange, W. Rist, H. F. Stahl, A. Weith, and M. C. Lenter Comment on "MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells" J. Immunol., March 15, 2008; 180(6): 3625 - 3625. [Full Text] [PDF] |
||||
![]() |
C. Baecher-Allan and D. A. Hafler Response to Comment on "MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells" J. Immunol., March 15, 2008; 180(6): 3626 - 3626. [Full Text] [PDF] |
||||
![]() |
B. Santner-Nanan, N. Seddiki, E. Zhu, V. Quent, A. Kelleher, B. F. de St Groth, and R. Nanan Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype Int. Immunol., March 1, 2008; 20(3): 375 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. D. van Mierlo, H. U. Scherer, M. Hameetman, M. E. Morgan, R. Flierman, T. W. J. Huizinga, and R. E. M. Toes Cutting Edge: TNFR-Shedding by CD4+CD25+ Regulatory T Cells Inhibits the Induction of Inflammatory Mediators J. Immunol., March 1, 2008; 180(5): 2747 - 2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Tiemessen, A. L. Jagger, H. G. Evans, M. J. C. van Herwijnen, S. John, and L. S. Taams CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages PNAS, December 4, 2007; 104(49): 19446 - 19451. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Borsellino, M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Hopner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression Blood, August 15, 2007; 110(4): 1225 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Brusko, C. Wasserfall, K. McGrail, R. Schatz, H. L. Viener, D. Schatz, M. Haller, J. Rockell, P. Gottlieb, M. Clare-Salzler, et al. No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes Diabetes, March 1, 2007; 56(3): 604 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kinter, J. McNally, L. Riggin, R. Jackson, G. Roby, and A. S. Fauci Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals PNAS, February 27, 2007; 104(9): 3390 - 3395. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nadkarni, C. Mauri, and M. R. Ehrenstein Anti-TNF-{alpha} therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-{beta} J. Exp. Med., January 22, 2007; 204(1): 33 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells J. Exp. Med., July 10, 2006; 203(7): 1693 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, A. L. Putnam, Z. Xu-yu, G. L. Szot, M. R. Lee, S. Zhu, P. A. Gottlieb, P. Kapranov, T. R. Gingeras, B. F. de St. Groth, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells J. Exp. Med., July 10, 2006; 203(7): 1701 - 1711. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |